Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naval Daver

Showing results (41-50 of 434) with videos related to

Pageof 44
Sort By:
Frontiers in Oncology|November 30, 2020
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future DirectionsBachar Samra, Marina Konopleva, Alessandro Isidori, et al.
Statistics in Medicine|June 8, 2021
A Bayesian hierarchical monitoring design for phase II cancer clinical trials: Incorporating information on response duration into monitoring rulesJian Wang, Junsheng Ma, Chunyan Cai, et al.
Blood Cancer Discovery|January 11, 2022
Checkpoint Blockade + Chemotherapy: the Right Combination for AML?Spencer C Wei, James J Mancuso, Naval Daver, et al.
Leukemia|January 18, 2019
Targeting FLT3 mutations in AML: review of current knowledge and evidenceNaval Daver, Richard F Schlenk, Nigel H Russell, et al.
Leukemia & Lymphoma|September 25, 2019
CPX-351 (vyxeos) in AMLMansour Alfayez, Hagop Kantarjian, Tapan Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2012
Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic optionsNaval Daver, Aziz Nazha, Hagop M Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2017
Diagnostic Challenges of Hemophagocytic LymphohistiocytosisZaher K Otrock, Naval Daver, Hagop M Kantarjian, et al.
JCO Precision Oncology|April 9, 2019
Systemic Immunotherapy Effective for Refractory Extramedullary Acute Myeloid LeukemiaMansour Alfayez, Doina Ivan, Naveen Pemmaraju, et al.
Cancer Management and Research|October 22, 2019
Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient SelectionHussein A Abbas, Mansour Alfayez, Tapan Kadia, et al.
Leukemia Research|March 22, 2017
Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevancePaolo Strati, Lucia Masarova, Prithviraj Bose, et al.
Pageof 44

Showing results (41-50 of 434) with videos related to

Sort By:
Pageof 44
Frontiers in Oncology|November 30, 2020
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future DirectionsBachar Samra, Marina Konopleva, Alessandro Isidori, et al.
Statistics in Medicine|June 8, 2021
A Bayesian hierarchical monitoring design for phase II cancer clinical trials: Incorporating information on response duration into monitoring rulesJian Wang, Junsheng Ma, Chunyan Cai, et al.
Blood Cancer Discovery|January 11, 2022
Checkpoint Blockade + Chemotherapy: the Right Combination for AML?Spencer C Wei, James J Mancuso, Naval Daver, et al.
Leukemia|January 18, 2019
Targeting FLT3 mutations in AML: review of current knowledge and evidenceNaval Daver, Richard F Schlenk, Nigel H Russell, et al.
Leukemia & Lymphoma|September 25, 2019
CPX-351 (vyxeos) in AMLMansour Alfayez, Hagop Kantarjian, Tapan Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2012
Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic optionsNaval Daver, Aziz Nazha, Hagop M Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2017
Diagnostic Challenges of Hemophagocytic LymphohistiocytosisZaher K Otrock, Naval Daver, Hagop M Kantarjian, et al.
JCO Precision Oncology|April 9, 2019
Systemic Immunotherapy Effective for Refractory Extramedullary Acute Myeloid LeukemiaMansour Alfayez, Doina Ivan, Naveen Pemmaraju, et al.
Cancer Management and Research|October 22, 2019
Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient SelectionHussein A Abbas, Mansour Alfayez, Tapan Kadia, et al.
Leukemia Research|March 22, 2017
Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevancePaolo Strati, Lucia Masarova, Prithviraj Bose, et al.
Pageof 44